Clinical Trial: European Quality Improvement Programme for Acute Coronary Syndromes
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Improving the Management of Non-ST Elevation Acute Coronary Syndrome: Systematic Evaluation of a Quality Improvement Programme
Brief Summary: The main hypothesis to be tested is that the use of a quality improvement programme will lead to measurable improvements in the management of care and use of evidence based treatments for patients presenting to hospital with non-ST elevation acute coronary syndromes.
Detailed Summary:
Sponsor: Royal Brompton & Harefield NHS Foundation Trust
Current Primary Outcome: Composite of 7 outcome measures to assess aggregate potential for improvement in care using the QI programme:1:risk stratification within 24 hrs, 2:early coronary angiography, 3:anticoagulation, 4:beta-blockers, 5:statins, 6:ACE-inhibitors, 7:Clopidogrel [ Time Frame: 10 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Clinical outcomes at discharge including death and myocardial infarction [ Time Frame: 10 months ]
- Estimated costs of care for patients [ Time Frame: 10 months ]
- Estimated costs and economic evaluation of potential cost-effectiveness of QI programme [ Time Frame: 10 months ]
Original Secondary Outcome: Same as current
Information By: Royal Brompton & Harefield NHS Foundation Trust
Dates:
Date Received: July 11, 2008
Date Started: August 2007
Date Completion: February 2009
Last Updated: July 15, 2008
Last Verified: July 2008
